Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunxin Chen

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2015
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted TherapyColin Phipps, Yunxin Chen, Daryl Tan
Current Osteoporosis Reports|August 12, 2025
Ageing-Related Changes in Ultrastructural Bone Matrix Composition and Osteocyte MechanosensitivityYunxin Chen, Jenneke Klein-Nulend, Nathalie Bravenboer
BMC Ophthalmology|November 24, 2022
Upregulation of PCED1B-AS1 in proliferative diabetic retinopathy and its involvement in retinal vascular endothelial cell proliferationXuyang Wang, Wangling Chen, Wei Lao, et al.
Therapeutic Advances in Hematology|July 3, 2015
Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical developmentColin Phipps, Yunxin Chen, Sathish Gopalakrishnan, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 9, 2025
Mechanisms of Erythropoietin-Mediated Protection Against Retinal Ganglion Cell ApoptosisWangling Chen, Wei Lao, Yunxin Chen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 7, 2022
Silencing LncRNA PVT1 Reverses High Glucose-Induced Regulation of the High Expression of PVT1 in HRMECs by Targeting miR-128-3pXuyang Wang, Wangling Chen, Wei Lao, et al.
Blood Advances|June 12, 2024
Beyond BCMA: newer immune targets in myelomaMelinda S Y Tan, Yunxin Chen, Eric L Smith
Advances in Therapy|May 20, 2021
Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based AnalysisJinpo Wang, Rongfeng Huang, Yuehong Huang, et al.
Panminerva Medica|September 21, 2020
BCMA-targeting approaches for treatment of multiple myelomaYunxin Chen, Chandramouli Nagarajan, Melinda S Tan, et al.
Blood Cells, Molecules & Diseases|December 27, 2016
Concurrent β-thalassaemia trait and Southeast Asian ovalocytosis associated with clinically significant iron loadingYunxin Chen, Hai Yang Law, Guek Peng Tan, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2015
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted TherapyColin Phipps, Yunxin Chen, Daryl Tan
Current Osteoporosis Reports|August 12, 2025
Ageing-Related Changes in Ultrastructural Bone Matrix Composition and Osteocyte MechanosensitivityYunxin Chen, Jenneke Klein-Nulend, Nathalie Bravenboer
BMC Ophthalmology|November 24, 2022
Upregulation of PCED1B-AS1 in proliferative diabetic retinopathy and its involvement in retinal vascular endothelial cell proliferationXuyang Wang, Wangling Chen, Wei Lao, et al.
Therapeutic Advances in Hematology|July 3, 2015
Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical developmentColin Phipps, Yunxin Chen, Sathish Gopalakrishnan, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 9, 2025
Mechanisms of Erythropoietin-Mediated Protection Against Retinal Ganglion Cell ApoptosisWangling Chen, Wei Lao, Yunxin Chen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 7, 2022
Silencing LncRNA PVT1 Reverses High Glucose-Induced Regulation of the High Expression of PVT1 in HRMECs by Targeting miR-128-3pXuyang Wang, Wangling Chen, Wei Lao, et al.
Blood Advances|June 12, 2024
Beyond BCMA: newer immune targets in myelomaMelinda S Y Tan, Yunxin Chen, Eric L Smith
Advances in Therapy|May 20, 2021
Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based AnalysisJinpo Wang, Rongfeng Huang, Yuehong Huang, et al.
Panminerva Medica|September 21, 2020
BCMA-targeting approaches for treatment of multiple myelomaYunxin Chen, Chandramouli Nagarajan, Melinda S Tan, et al.
Blood Cells, Molecules & Diseases|December 27, 2016
Concurrent β-thalassaemia trait and Southeast Asian ovalocytosis associated with clinically significant iron loadingYunxin Chen, Hai Yang Law, Guek Peng Tan, et al.
Pageof 8